Market Place
Sourcing Support
ElevateBio Advances Lipid Nanoparticle Delivery Platform For Liver
16 Oct 2024 //
GLOBENEWSWIRE
ElevateBio Announces New US Gene Editing Patents
14 May 2024 //
GLOBENEWSWIRE
Xcell Biosciences Announces Collaboration with ElevateBio
11 Jan 2024 //
BUSINESSWIRE
ElevateBio to Highlight Growth of Business Driven By Gene Editing Partnerships
08 Jan 2024 //
BUSINESSWIRE
After massive $401M raise, ElevateBio lets 13% of staff go
26 Oct 2023 //
FIERCE BIOTECH
ElevateBio Announces $401 M Series D Financing to Further Accelerate Growth
24 May 2023 //
BUSINESSWIRE
ElevateBio Announces Presentations at the (ASGCT) Annual Meeting
16 May 2023 //
BUSINESSWIRE
ElevateBio and Affini-T partner on KRAS therapies; Casma raises $46M
15 Nov 2022 //
ENDPTS
ElevateBio finds a new manufacturing home & gene therapy partner in Pittsburgh
26 Aug 2022 //
BIOPHARMADIVE
ElevateBio Partners with the California Institute for Regenerative Medicine
23 Aug 2022 //
BUSINESSWIRE
ElevateBio Forms a New Company With George Daley and Boston Children’s Hospital
04 Aug 2022 //
BUSINESSWIRE
ElevateBio Receives U.S. Patent Providing Protection for RNA-Guided Nucleases
15 Nov 2021 //
BIOSPACE
ElevateBio buys editing tech to support gene therapy pipeline
28 Oct 2021 //
FIERCEBIOTECH
Dovetail` partnership meant to turn Boston Children`s into a hub for startups
09 Jul 2021 //
BIOPHARMADIVE
Boston Children’s Hospital and ElevateBio Announce Five-Year Collaboration
29 Jun 2021 //
BUSINESSWIRE
M. Roberts Joins ElevateBio as Scientific Advisor for its Immunotherapy Platform
10 Jun 2021 //
BUSINESSWIRE
ElevateBio adds another $525M to its war chest as it looks to build on next-gen
16 Mar 2021 //
ENDPTS
ElevateBio Scales Disruptive Cell and Gene Therapy Business Model with $525 M
15 Mar 2021 //
BUSINESSWIRE
ElevateBio to Present at the Piper Sandler 32nd Annual Virtual Conference
23 Nov 2020 //
BUSINESSWIRE
TCR² Therapeutics, ElevateBio Expand TC-210 Mfg. Capacity
11 Nov 2020 //
CONTRACT PHARMA
Eleva`s Drug Candidate to Be Examined for Use in COVID-19 Treatment
02 Jun 2020 //
PRNEWSWIRE
ElevateBio to Present at the Jefferies Virtual Healthcare Conference
26 May 2020 //
BUSINESSWIRE
David Hallal bags another whopper round looking recruit more cell & gene therapy
31 Mar 2020 //
ENDPTS
ElevateBio Closes $170 Million Series B Financing
30 Mar 2020 //
BUSINESSWIRE
ElevateBio founds HighPassBio to develop Fred Hutch cell therapy
02 Oct 2019 //
FIERCE BIOTECH
Biotech builder ElevateBio reveals its first portfolio company: AlloVir
23 May 2019 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.